Baker Tilly Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Baker Tilly Wealth Management, LLC

  • $377 Million
  • Q4 2025

A detailed history of Baker Tilly Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 5,815 shares of BMY stock, worth $272,200. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,815
Previous 6,528 10.92%
Holding current value
$272,200
Previous $294,000 7.48%
% of portfolio
0.07%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026
SELL
$42.6 - $49.08 $30,373 - $34,994
-713 Reduced 10.92%
5,815 $272,000
Q3 2025

Oct 09, 2025
BUY
$43.31 - $48.98 $27,458 - $31,053
634 Added 10.76%
6,528 $294,000
Q2 2025

Jul 10, 2025
SELL
$44.12 - $59.6 $46,855 - $63,295
-1,062 Reduced 15.27%
5,894 $272,000
Q1 2025

Apr 09, 2025
BUY
$53.9 - $63.11 $49,102 - $57,493
911 Added 15.07%
6,956 $424,000
Q4 2024

Jan 10, 2025
BUY
$51.92 - $59.94 $8,047 - $9,290
155 Added 2.63%
6,045 $341,000
Q3 2024

Oct 24, 2024
SELL
$39.66 - $51.75 $90,147 - $117,627
-2,273 Reduced 27.85%
5,890 $304,000
Q2 2024

Jul 18, 2024
SELL
$40.25 - $52.99 $370,340 - $487,560
-9,201 Reduced 52.99%
8,163 $339,000
Q1 2024

May 09, 2024
SELL
$47.98 - $54.4 $623 - $707
-13 Reduced 0.07%
17,364 $941,000
Q4 2023

Jan 10, 2024
SELL
$48.48 - $57.85 $66,756 - $79,659
-1,377 Reduced 7.34%
17,377 $891,000
Q3 2023

Oct 10, 2023
SELL
$57.89 - $64.73 $80,872 - $90,427
-1,397 Reduced 6.93%
18,754 $1.09 Million
Q2 2023

Jul 20, 2023
BUY
$63.71 - $70.74 $68,934 - $76,540
1,082 Added 5.67%
20,151 $1.29 Million
Q1 2023

Apr 12, 2023
BUY
$65.71 - $74.53 $4,928 - $5,589
75 Added 0.39%
19,069 $1.32 Million
Q4 2022

Jan 26, 2023
BUY
$68.48 - $81.09 $112,923 - $133,717
1,649 Added 9.51%
18,994 $0
Q3 2022

Oct 20, 2022
SELL
$0.13 - $76.84 $140 - $82,987
-1,080 Reduced 5.86%
17,345 $1.23 Million
Q2 2022

Jul 28, 2022
SELL
$72.62 - $79.98 $35,293 - $38,870
-486 Reduced 2.57%
18,425 $1.42 Million
Q1 2022

Apr 27, 2022
BUY
$61.48 - $73.72 $137,346 - $164,690
2,234 Added 13.4%
18,911 $1.38 Million
Q4 2021

Feb 08, 2022
BUY
$53.63 - $62.52 $32,124 - $37,449
599 Added 3.73%
16,677 $1.04 Million
Q3 2021

Nov 02, 2021
BUY
$59.17 - $69.31 $123,073 - $144,164
2,080 Added 14.86%
16,078 $951,000
Q2 2021

Jul 30, 2021
BUY
$61.91 - $67.42 $96,703 - $105,310
1,562 Added 12.56%
13,998 $935,000
Q1 2021

Apr 28, 2021
BUY
$59.34 - $66.74 $143,009 - $160,843
2,410 Added 24.04%
12,436 $785,000
Q4 2020

Feb 03, 2021
BUY
$57.74 - $65.43 $578,901 - $656,001
10,026 New
10,026 $622,000

Others Institutions Holding BMY

# of Institutions
2,703
Shares Held
1.58B
Call Options Held
28M
Put Options Held
28.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Baker Tilly Wealth Management, LLC Portfolio

Follow Baker Tilly Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email